• Tue news: Regeneron fails to block Eylea biosimilar. Inside the GLP-1 price war. Novartis inks $1B biobucks deal. UCB/Biogen lupus drug. Lilly Alzheimer’s drug approved in Japan. See more on our front page

severeence

  1. ***ATTENTION ALL SEVERED EMPLOYEES USING COBRA***

    This affects "several hundred former employees" per Mercer Marketplace. Please read and inform any former employees who may, unknowingly, be in this situation. Allergan has gone back in time and decided that it payed too much toward health insurance premiums and retroactively readjusted their...
    • anonymous
    • Thread
    • cobra severeence
    • Replies: 0
    • Forum: Allergan
Top Bottom
Back